AN1 0.00% 0.7¢ anagenics limited

Broker data, page-42

  1. 1,487 Posts.
    lightbulb Created with Sketch. 65
    At SP $0.033, Mcap of $30.64mln & est cash of $2.5mln without debt, CDY's EV is $28.14mln

    On the verge of multiple international Advangen rollouts, an additional $10mln in the bank ($12.5mln Cash v $2.5mln cash) should translate to a large increase in EV as well as mcap)

    Lets assume the entire amount were directed to Advangen and it's US rollout and not the more valuable Mk SBU's.
    $10mln - est $1mln (Rollout costs) leaves 9mln for COGs.
    At 70%+ margin, this equates to 30mln in expected sales (9mln / (1 - 70%)) or an 21mln increase in cash.
    $28.14mln EV + 2.5mln cash already on hand + 21mln increase = $51.64mln Mcap
    This would equate to an Mcap 23.5 million above where it is today.
    With 1.227mln FPO on issue, using this logic CDYO conversion would contribute a $0.009 increase in SP.

    This is just an example calc. of my weighing up ROA against dilution. It highlights that a CDYO conversion is more positive for the CDY share price then lapse & the additional $10mln in the kitty should be factored into the SP as conversion date approaches.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 775527 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 5022 1
View Market Depth
Last trade - 16.12pm 12/08/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.